Logo (WIPO, 01/03/2018)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark was filed as Figurative mark on 01/03/2018 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Other polygons #Colours #One polygon #Polygons containing one or more triangles or lines forming an angle (specify the content) #Polygons containing one or more other geometrical figures (specify the content) #Two predominant colours
| Trademark form | Figurative mark |
| File reference | 1408354 |
| Countries | 
|
| Base trademark |
No. 87565885,
August 11, 2017
|
| Application date | January 3, 2018 |
| Expiration date | January 3, 2028 |
Trademark owner
8717 W 110th Street, Suite 300
Overland Park KS 66210
US
Overland Park KS 66210
US
Trademark representatives
10801 Mastin Blvd., Suite 1000
Overland Park KS 66210
US
goods and services
35
Business information and business consulting services,
namely, providing business advisory services to identify,
screen, and select contract manufacturing organizations to
contract and build medical and pharmaceutical products and
devices; providing business advisory services to health care
providers, namely, designing the administrative, financial
and clinical workflows associated with value-based
healthcare delivery models; providing business assistance to
healthcare providers in the field of enabling communication
and collaboration for the purpose of developing,
implementing and evaluating patient care plans; business
services, namely, tracking and monitoring regulatory
requirements in the pharmaceutical, biotechnology, and
medical fields for business purposes; maintaining files and
records concerning the medical condition of individuals;
maintaining personal medical history records and files;
business consulting services in the medical, pharmaceutical,
and biotechnology fields
42
Providing quality assurance services in the medical,
pharmaceutical, and biotechnology fields; quality management
services, namely, quality evaluation and analysis, quality
assurance, and quality control, in the medical,
pharmaceutical, and biotechnology fields; testing, analysis,
and evaluation of medical, pharmaceutical, and biotechnology
services to assure compliance with industry standards;
tracking and monitoring regulatory requirements in the
pharmaceutical, biotechnology, and medical fields for
quality control purposes; consulting services in the
biotechnology field
44
Consulting services in the medical and pharmaceutical
fields; providing medical and pharmaceutical information
services, namely, drug interaction call centers, adverse
event reporting services for drugs and medical devices and
product compliant reporting services for drugs and medical
device; medical information; providing medical information,
consultancy and advisory services; health care consulting,
namely, aggregating clinical, claims, socioeconomic and
behavioral health data for the purpose of improving
healthcare providers' evaluation of health conditions and
health risks with individual patients, cohorts of patients,
and populations; health care consulting, namely, assessing
patient and population health profiles using evidence-based
medical guidelines for the purpose of improving healthcare
provider treatment decisions at the point of care; providing
information over a global computer network in the field of
health care; providing medical information, consultancy, and
advisory services, namely, providing healthcare providers,
insurance companies, and healthcare product manufacturers
with information and statistics regarding patient medication
intake, schedule compliance, and health status
45
Regulatory compliance consulting in the pharmaceutical,
biotechnology, and medical fields; regulatory compliance
consulting in the fields of drug and device development and
manufacturing; tracking and monitoring regulatory
requirements in the pharmaceutical, biotechnology, and
medical fields for legal or regulatory compliance purposes;
tracking and monitoring regulatory requirements in the field
of drug and device development and manufacturing for
regulatory compliance purposes
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 27, 2021 | 2021/6 Gaz | RAW: Holder Rights Restriction | |
| March 14, 2019 | 2019/27 Gaz | JP | Rejection |
| February 27, 2019 | 2019/10 Gaz | CN | Rejection |
| February 19, 2019 | 2019/27 Gaz | AU | Rejection |
| February 6, 2019 | 2019/6 Gaz | GB | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| January 15, 2019 | 2019/7 Gaz | CN | Rejection |
| November 23, 2018 | 2018/49 Gaz | EM | Rejection |
| July 27, 2018 | 2018/32 Gaz | GB | Rejection |
| January 3, 2018 | US | Registration |
ID: 141408354